Fons, France

Benoît Maisonneuve

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Grenoble Alpes. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Benoît Maisonneuve: Innovator in Microfluidic Device Technology

Introduction

Benoît Maisonneuve is a notable inventor based in Fons, France. He has made significant contributions to the field of microfluidics, particularly through his innovative patent that addresses the manufacturing of microfluidic devices. His work has implications for various applications, including biomedical research and diagnostics.

Latest Patents

Benoît Maisonneuve holds a patent titled "Sizing of a microfluidic device for confining a sample." This invention relates to a method for manufacturing a microfluidic device that includes an input zone for receiving a carrier fluid medium and a sample in suspension. The device is designed to confine a selected amount of the sample, which may consist of cells or microparticles, and includes an output zone for discharging the carrier fluid medium along with the sample.

Career Highlights

Throughout his career, Benoît Maisonneuve has worked with prestigious institutions such as Université Grenoble Alpes and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Benoît has collaborated with Thibault Honegger, enhancing the development of innovative solutions in microfluidics. Their partnership has fostered advancements in the technology and its applications.

Conclusion

Benoît Maisonneuve's contributions to microfluidic device technology exemplify the impact of innovation in scientific research. His patent and collaborations highlight the importance of advancing methodologies in this critical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…